RESEARCH PAPER
Figure from article: Integrated gene expression...
 
KEYWORDS
TOPICS
ABSTRACT
Background:
Polycystic ovary syndrome (PCOS) affects millions of women worldwide and is primarily known for its reproductive and hormonal symptoms. However, growing evidence suggests a strong link between PCOS and inflammation. Rheumatoid arthritis (RA) and osteoarthritis (OA) similarly involve systemic inflammation and immune dysregulation. Despite their distinct clinical manifestations, these disorders may share overlapping biological pathways. This study aimed to identify shared transcriptomic signatures between PCOS and autoimmune joint diseases such as RA and OA.

Material and methods:
RNA sequencing datasets were downloaded from the publicly available Gene Expression Omnibus (GEO) database. After processing and quality filtering, a total of 73 samples from the GSE277906 and GSE89408 datasets were selected. DEG analysis was conducted using the DESeq2 package in RStudio by adjusting for a significant p-value < 0.1 and |log2 fold change| > 0.5. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed to determine functional enrichment of genes and common pathways associated with the diseases.

Results:
A total of 10,492 and 9,892 DEGs were identified in PCOS vs. RA and PCOS vs. OA, respec tively. Key genes dysregulated among the diseases included TOMM34, DHCR24, CMAS, RBP1, and HSD3B2, and the enrichment analysis revealed overlapping pathways involving immune regulation, mitochondrial dysfunction, oxidative stress, and proteasome activity. Notably, 201 GO pathways were shared by PCOS and OA, 123 by RA and OA, and 267 by PCOS and RA. All three conditions shared a set of 57 GO pathways, including mitophagy and ER stress.

Conclusions:
The identified common pathways signify the overlap between PCOS, RA, and OA. These findings support the hypothesis of systemic immunometabolic involvement in PCOS.
REFERENCES (39)
1.
Almanza A, Carlesso A, Chintha C, Creedican S, Doultsinos D, Leuzzi B, Luís A, McCarthy N, Montibeller L, More S, et al. 2019. Endoplasmic reticulum stress signalling – from basic mechanisms to clinical applications. FEBS J. 286(2): 241–278.
 
2.
Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko M, et al. 2013. NCBI GEO: archive for functional genomics data sets – update. Nucleic Acids Res. 41(Database issue): D991–D995.
 
3.
Barry JA, Azizia MM, Hardiman PJ. 2014. Risk of endometrial, ovarian and breast cancer in women with PCOS: a systematic review and meta-analysis. Hum Reprod Update. 20(5): 748–758.
 
4.
Bartok B, Firestein GS. 2010. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 233(1): 233–255.
 
5.
Bhakta A, Gambhir L, Verma R. 2025. Pathogenesis and treatment of rheumatoid arthritis with focus on herbal therapeutic approaches (Review). World Acad Sci J. 7: 57. https://doi.org/10.3892/wasj.2....
 
6.
Bogari NM. 2020. Genetic construction between polycystic ovarian syndrome and type 2 diabetes. Saudi J Biol Sci. 27(10): 2539–2543.
 
7.
Cao H, Zhou X, Xu B, Hu H, Guo J, Wang M, Li N, Jun Z. 2024. Advances in the study of mitophagy in osteoarthritis. J Zhejiang Univ Sci B. 25(3): 197–211.
 
8.
Chen X, Shi C, He M, Xiong S, Xia X. 2023. Endoplasmic reticulum stress: molecular mechanism and therapeutic targets. Signal Transduct Target Ther. 8: 352. https://doi.org/10.1038/s41392....
 
9.
Chen Y, Xie M, Wu S, Deng Z, Tang Y, Guan Y, Ye Y, He Q, Li L. 2024. Multi-omics approach to reveal follicular metabolic changes and their effects on oocyte competence in PCOS patients. Front Endocrinol (Lausanne). 15: 1426517. https://doi.org/10.3389/fendo.....
 
10.
Courties A, Gualillo O, Berenbaum F, Sellam J. 2015. Metabolic stress-induced joint inflammation and osteoarthritis. Osteoarthritis Cartilage. 23(11): 1955–1965.
 
11.
Dan J, Lu HM, Zhou X, Wang HY, Wang JH. 2024. Association of autoimmune diseases with the occurrence of osteoarthritis: a gene expression and Mendelian randomization study. Front Med (Lausanne). 11: 1435312. https://doi.org/10.3389/fmed.2....
 
12.
Devarbhavi P, Telang L, Vastrad B, Vastrad C, Kotturshetti I, Chandrashekar R. 2021. Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules. Reprod Biol Endocrinol. 19(1): 31. https://doi.org/10.1186/s12958....
 
13.
Divya K, Mounisha B, Sowmya RV. 2024. Prevalence of polycystic ovarian syndrome among young women who attended a tertiary care hospital, Visakhapatnam. Int J Curr Pharm Sci. 16(4): 75–78.
 
14.
Gilbert EW, Tay CT, Hiam DS, Teede HJ, Moran LJ. 2018.Comorbidities and complications of polycystic ovary syndrome: an overview of systematic reviews. Hum Reprod. 89(6): 683–699.
 
15.
Ghowsi M, Khazali H, Sisakhtnezhad S. 2018. Evaluation of TNF-a and IL-6 mRNA expressions in visceral and subcutaneous adipose tissues of polycystic ovarian rats and effects of resveratrol. Iran J Basic Med Sci. 21(2): 165–174.
 
16.
Gupta M, Singh D, Toppo M, Priya A, Sethia S, Gupta P. 2017. A cross-sectional study of polycystic ovarian syndrome among young women in Bhopal, Central India. Int J Community Med Public Health. 5(1): 95–100.
 
17.
Guo Y, Walsh AM, Fearon U, Smith MD, Wechalekar MD, Yin X, Cole S, Orr C, McGarry T, Canavan M, et al. 2017.CD40L-dependent pathway is active at various stages of rheumatoid arthritis disease progression. J Immunol. 198(11): 4490–4501.
 
18.
Hagenauer MH, Sannah Y, Hebda-Bauer EK, Rhoads C, O’Connor AM, Watson SJ Jr, Akil H. 2024. Resource: a curated database of brain-related functional gene sets (Brain.GMT). MethodsX. 13: 102788. https://doi.org/10.1016/j.mex.....
 
19.
Joshi B, Mukherjee S, Patil A, Purandare A, Chauhan S, Vaidya R. 2014. A cross-sectional study of polycystic ovarian syndrome among adolescent and young girls in Mumbai, India. Indian J Endocrinol Metab. 18(3): 317–324.
 
20.
Kluzek S, Rubin KH, Sanchez-Santos M, O’Hanlon MS, Andersen M, Glintborg D, Abrahamsen B. 2021. Accelerated osteoarthritis in women with polycystic ovary syndrome: a prospective nationwide registry-based cohort study. Arthritis Res Ther. 23(1): 225. https://doi.org/10.1186/s13075....
 
21.
Koike H, Harada M, Kusamoto A, Xu Z, Tanaka T, Sakaguchi N, Kunitomi C, Azhary JMK, Takahashi N, Urata Y, et al. 2023. Roles of endoplasmic reticulum stress in the pathophysiology of polycystic ovary syndrome. Front Endocrinol (Lausanne). 14: 1124405. https://doi.org/ 10.3389/fendo.2023.1124405.
 
22.
Legro RS, Kunselman AR, Dodson WC, Dunaif A. 1999. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in PCOS. J Clin Endocrinol Metab. 84(1): 165–169.
 
23.
Lingaiah S, Morin-Papunen L, Piltonen T, Puurunen J, Sundström-Poromaa I, Stener-Victorin E, Bloigu R, Risteli J, Tapanainen JS. 2017. Bone markers in polycystic ovary syndrome: a multicentre study. Clin Endocrinol (Oxf). 87(6): 673–679.
 
24.
Liu X, Zhang J, Wang X, Zhang Z. 2024. Transcriptomic analysis identifies diagnostic genes in polycystic ovary syndrome and periodontitis. Eur J Med Res. 29(1): 3. https://doi.org/10.1186/s40001....
 
25.
Mizgier M, Sansoni V, Więckowska B, Jarząbek-Bielecka G, Formanowicz D, Kędzia W, Banfi G, Lombardi G. 2025.Correlations between serum bone biomarkers and metabolic, hormonal, inflammatory, and redox parameters in lean and overweight PCOS adolescent girls. Front Nutr. 12: 1477992. https://doi.org/10.3389/fnut.2....
 
26.
Moulin D, Sellam J, Berenbaum F, Guicheux J, Boutet MA. 2025. The role of the immune system in osteoarthritis: mechanisms, challenges and future directions. Nat Rev Rheumatol. 21(4): 221–236.
 
27.
Pallavi K, Harshitha K. 2024. Study of prevalence of polycystic ovarian syndrome among adolescent and young adult students of Navodaya group of institutions. Int J Curr Pharm Sci. 16(4): 37–40.
 
28.
Robinson WH, Lepus CM, Wang Q, Raghu H, Mao R, Lindstrom TM, Sokolove J. 2016. Low-grade inflammation as a key mediator of OA pathogenesis. Nat Rev Rheumatol. 12(10): 580–592.
 
29.
Rudnicka E, Kunicki M, Suchta K, Machura P, Grymowicz M, Smolarczyk R. 2020. Inflammatory markers in women with polycystic ovary syndrome. Biomed Res Int. 2020: 4092470. https://doi.org/10.1155/2020/4....
 
30.
Rudnicka E, Suchta K, Grymowicz M, Calik-Ksepka A, Smolarczyk K, Duszewska AM, Smolarczyk R, Meczekalski B. 2021. Chronic low-grade inflammation in the pathogenesis of PCOS. Int J Mol Sci. 22(7): 3789. https://doi.org/10.3390/ijms22....
 
31.
Sharmeen S, Nomani H, Taub E, Carlson H, Yao Q. 2021. Polycystic ovary syndrome: epidemiologic assessment of prevalence of systemic rheumatic and autoimmune diseases. Clin Rheumatol. 40(12): 4837–4843.
 
32.
Siemers KM, Klein AK, Baack ML. 2023. Mitochondrial dysfunction in PCOS: insights into reproductive organ pathophysiology. Int J Mol Sci. 24(17): 13123. https://doi.org/ 10.3390/ijms241713123.
 
33.
Skiba MA, Islam RM, Bell RJ, Davis SR. 2018. Understanding variation in prevalence estimates of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 24(6): 694–709.
 
34.
Sneha S, Hiremath SA. 2024. The role of inflammatory pathways in PCOS-related infertility and pregnancy complications. Eur J Cardiovasc Med. 14(6): 679–684.
 
35.
Vasyukova E, Zaikova E, Kalinina O, Gorelova I, Pyanova I, Bogatyreva E, Vasilieva E, Grineva E, Popova P. 2023. Inflammatory and anti-inflammatory parameters in PCOS patients depending on body mass index: a case-control study. Biomedicines 11(10): 2791. https://doi.org/10.3390/biomed....
 
36.
Walsh AM, Wechalekar MD, Guo Y, Yin X, Weedon H, Proudman SM, Smith MD, Nagpal S. 2017. Triple DMARD treatment in early rheumatoid arthritis modulates synovial T cell activation and plasmablast/plasma cell differentiation pathways. PLoS One. 12(9): e0183928. https://doi.org/10.1371/journa....
 
37.
Yu O, Christ JP, Schulze-Rath R, Covey J, Kelley A, Grafton J, Cronkite D, Holden E, Hilpert J, Sacher F, et al. 2023.Incidence, prevalence, and trends in polycystic ovary syndrome diagnosis: a United States population-based study from 2006 to 2019. Am J Obstet Gynecol. 229(1): 39.e1–39.e12. https://doi.org/10.1016/j.ajog....
 
38.
Zeber-Lubecka N, Ciebiera M, Hennig EE. 2023. Polycystic ovary syndrome and oxidative stress – from bench to bedside. Int J Mol Sci. 24(18): 14126. https://doi.org/10.3390/ijms24....
 
39.
Zhang J, Bao Y, Zhou X, Zheng L. 2019. Polycystic ovary syndrome and mitochondrial dysfunction. Reprod Biol Endocrinol. 17(1): 67. https://doi.org/10.1186/s12958....
 
eISSN:2353-9461
ISSN:0860-7796
Journals System - logo
Scroll to top